Article
Novel Mutation in CECR1 Leads to Deficiency of ADA2 with Associated Neutropenia.
Journal of clinical immunology - 1 Apr 2018
Cipe Funda Erol, Aydogmus Cigdem, Serwas Nina K, Keskindemirci Gonca, Boztuğ Kaan
Abstract excerpt
PURPOSE: Adenosine deaminase 2 (ADA2) have been reported to cause vasculitic diseases and immunodeficiency recently. Patients present with stroke episodes and rashes mimicking polyarteritis nodosa (PAN). We report a patient who has been followed up with severe neutropenia and found an unexpectedly revealed novel mutation in CECR1 affecting ADA2. METHODS: We reviewed medical records and clinical history of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
